EKF Diagnostics Holdings Plc (EKF)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 24.30 |
|---|---|
| 52-week range | 21.80 – 29.00 |
| Return, 1 month / 3 months | −5.3% / −6.5% |
| Return, 1 year / 3 years | −13.1% / −2.5% |
| Trend | Below its 200-day average |
| RSI (14) | 45 |
| Volatility (1 year) | 40.4% |
| Worst drawdown (1 year) | -17.7% |
| Average daily value traded | 10.39M GBX |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
EKF Diagnostics Holdings is a healthcare company based in Cardiff, Wales, that develops and supplies point-of-care testing equipment and reagents used in clinics, hospitals and laboratories. Its products include analysers and test kits for measuring blood glucose, lactate and haemoglobin, along with sample handling and processing products. The company also offers contract manufacturing services, producing diagnostic and life science products for other healthcare businesses, and sells into medical and scientific markets internationally.
EKF Diagnostics Holdings Plc trades under the code EKF on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
EKF Diagnostics Holdings Plc (EKF) trades on the London Exchange in UK. It last closed at GBX 24.30 on 23 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 1,974 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 13.1% and over the last three months it fell 6.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 45 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -4.9% | ||
| From 52-week high | -14.4% | ||
| Momentum | 36 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -6.5% | ||
| 6-month return | -3.8% | ||
| 12-month return, skipping the last month | -8.2% | ||
| Stability (higher is calmer) | 60 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 40.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.7% | ||
| Liquidity | 74 · Strong | Trades actively. | |
| Average daily value traded | 10.39M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −2.8% |
|---|---|
| 1 month | −5.3% |
| 3 months | −6.5% |
| 6 months | −3.8% |
| 1 year | −13.1% |
| 3 years | −2.5% |
| 5 years | −67.5% |
Signals
| 50-day / 200-day average | 25.03 / 25.55 |
|---|---|
| Golden / death cross (60 days) | Death, 31 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.03 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Nov 2023 | GBP 0.0120 |
| 3 Nov 2022 | GBP 0.0120 |
| 4 Nov 2021 | GBP 0.0110 |
| 5 Nov 2020 | GBP 0.0100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.